Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 15Brain Neoplasms 15Glioma 9Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Neoplasms by Site 5Neoplasms by Histologic Type 5Hematologic Neoplasms 5Recurrence 4Neuroblastoma 4Astrocytoma 4Spinal Cord Neoplasms 3Lymphoproliferative Disorders 3Lung Neoplasms 3Colorectal Neoplasms 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Medulloblastoma 2Lymphoma 2Laryngeal Neoplasms 2Erdheim-Chester Disease 2Central Nervous System Neoplasms 2cyclopia sequence 1Vitamin D Deficiency 1

Interventions

Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Craniocerebral Trauma × CNS × Clear all
NCT02881957 2022-06-15

Hypovitaminosis D in Neurocritical Patients

University of Utah

Phase 2/3 Completed
274 enrolled 16 charts
CNS

Brain Neoplasms, Intracranial Aneurysm, Craniocerebral Trauma, Meningitis, Seizures, Spinal Cord Injuries, Vitamin D Deficiency, Critical Illness, Intracranial Hemorrhages, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡